Eli Lilly Loses Bid To Limit Ex-FDA Chief's Take In GLP-1 MDL

By George Woolston · May 20, 2026, 7:54 PM EDT

A Pennsylvania federal judge said Eli Lilly & Co. and plaintiffs in multidistrict litigation accusing it of downplaying side effects of weight loss drugs were talking past each other in a...

To view the full article, register now.

Documents

Case Information

Case Title

GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION

Case Number

2:24-md-03094

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 05, 2024